Jefferies Adjusts Noile-Immune Biotech's Price Target to 440 Yen From 800 Yen, Keeps at Buy
Jefferies Adjusts Noile-Immune Biotech's Price Target to 440 Yen From 800 Yen, Keeps at Buy
傑富瑞集團將Noile-Immune Biotech的目標股價從800日元調整爲440日元，維持買入水平
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間